Several of these TNFAIP3-associated diseases including type 1 diabetes, celiac disease and inflammatory bowel disease, are known to involve loss of intestinal barrier function [36], [37], [38]. This evidence concerns the gene TNFAIP3 and type 1 diabetes mellitus.